Lung Function in Bariatric Surgery Candidates
Completed
- Conditions
- Lung Function DecreasedObesity
- Registration Number
- NCT06421168
- Lead Sponsor
- China-Japan Friendship Hospital
- Brief Summary
This study aims to retrospectively investigate the impact of body mass index on lung function metrics, e.g. FEV1%, FVC%, FEV1/FVC%.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1834
Inclusion Criteria
- Subjects with obesity (BMI ≥ 27.5 kg/m2 according to Chinese guidelines, guidelines from the American Society for Metabolic and Bariatric Surgery and International Federation for the Surgery of Obesity and Metabolic Disorders);
- Age > 16 years;
- Complete preoperative pulmonary function tests
Exclusion Criteria
- Patients with a history of lung surgery and/or respiratory diseases (e.g. asthma, pulmonary emphysema, and interstitial pulmonary fibrosis).
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method FEV1, FVC, FEV1/FVC% in class 1, 2, and 3 obesity At the time of pulmonary function testing Class 1 obesity: 27.5 kg/m2 \< body mass index \< 32.5 kg/m2; Class 2 obesity: 32.5 kg/m2 \< body mass index \< 37.5 kg/m2; Class 2 obesity: body mass index \> 37.5 kg/m2.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link obesity to reduced FEV1 and FVC in bariatric surgery candidates?
How does BMI affect lung function biomarkers compared to standard-of-care assessments in obstructive sleep apnea patients?
Are there specific biomarkers that correlate with post-bariatric surgery improvement in FEV1/FVC ratios?
What adverse respiratory events are associated with rapid weight loss after bariatric surgery and how are they managed?
How do pulmonary function test results in NCT06421168 compare to similar observational studies on morbid obesity and restrictive lung disease?
Trial Locations
- Locations (1)
Yuntao Nie
🇨🇳Beijing, China
Yuntao Nie🇨🇳Beijing, China